Amgen CEO says weight loss drug can address 'patient persistence issue'

Amgen CEO Bob Bradway discussed his company's weight loss drug in an interview with CNBC's Jim Cramer.

# Amgen CEO says weight loss drug can address 'patient persistence issue' Amgen CEO Bob Bradway discussed his company's weight loss drug in an interview with CNBC's Jim Cramer. **Read the full article:** [CNBC](https://www.cnbc.com/2026/01/13/amgen-ceo-weight-loss-drug-can-address-patient-persistence-issue.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*